ClinicalTrials.gg
Active, not recruitingNCT06632587TIMELYUpdated Nov 9, 2026

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

An interventional study of Early cranioplasty and Standard-of-care cranioplasty in Craniocerebral Trauma, Stroke and Intracranial Hemorrhages, sponsored by Thomas Jefferson University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Thomas Jefferson University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 9, 2026Now Active, not recruitingStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Craniocerebral Trauma with a site in United States — 12 open to participants now, 17 under way, none of them phase 3. Craniocerebral Trauma · United States.

Planned enrollment
43rd of 61
44 · median 94
Started
2024
with 8 others
No phase
50 of 95
6 open now
Primary completion
2026-12
later than 8 of 16 live
Registered
88th of 95
by date

Among the 95 studies in Craniocerebral Trauma with a site in United States, this one is the 43rd largest by planned enrollment of the 61 interventional ones that give a count, is one of 9 that started in 2024, is one of 50 with no phase, reaches primary completion later than 8 of the 16 other live ones, and was the 88th registered.

Craniocerebral Trauma

253 studies on the registry are indexed under Craniocerebral Trauma; 45 are open to participants now.

Browse Craniocerebral Trauma studies →

Open to participants now

12 of the 95 studies in Craniocerebral Trauma with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 25 Craniocerebral Trauma studies recruiting now, 8 (32%) set no upper age limit and 14 (56%) stop at 75 or younger; 8 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Craniocerebral Trauma with a site in United States, or all of them as a file.
02

Study summary

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).

Read the detailed description

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).

The primary endpoint involves a comprehensive evaluation of long-term functional outcomes at 6 months post-injury ("injury" defined as "acute traumatic injury or source of increased intracranial pressure secondary to stroke or intracranial hemorrhage"). This assessment aims to determine whether the timing of cranioplasty influences patients' neurological recovery, cognitive function, and overall quality of life. By comparing the outcomes of patients who undergo standard of care cranioplasty with those who undergo early cranioplasty, the study seeks to provide valuable insights into the potential benefits of the latter approach.

The findings of this research hold the potential to guide clinical practice and inform decision-making for patients who have undergone DHC. By considering a range of complications and incorporating a robust statistical framework, the study contributes to a more nuanced understanding of the advantages and disadvantages associated with different cranioplasty timing strategies.

03

Conditions studied

  • Craniocerebral Trauma
  • Stroke
  • Intracranial Hemorrhages

Keywords

  • Decompressive hemicraniectomy
  • cranioplasty
  • cranial trauma
  • stroke
  • intracranial hemorrhage
  • intracerebral hemorrhage
  • neurosurgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults of age greater than or equal to 18 years at the time of acute traumatic injury or source of increased intracranial pressure secondary to stroke or intracranial hemorrhage necessitating decompressive hemicraniectomy (DHC)
  • Patient's cranial flap fulfills Craniectomy Contour Class A or B after 4 weeks postoperatively (doi:10.1227/ons.0000000000000689)
  • Medically optimized for general anesthesia/surgery

Exclusion criteria

Exclusion Criteria:

  • Active systemic infection in weeks 6-8 post-DHC leading up to cranioplasty (e.g. pneumonia, urinary tract infection, soft tissue infection, bacteremia)
  • Cranial infection in the post-DHC period
  • Patient deemed not appropriate for early cranioplasty by attending neurosurgeon
  • Patient mortality prior to 8 weeks post-injury ("injury" defined as "acute traumatic injury or source of increased intracranial pressure causing brain injury secondary to stroke or intracranial hemorrhage")
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Active comparator
    Early cranioplasty

    Cranioplasty procedure performed prior to 8 weeks following the initial decompressive hemicraniectomy.

    Procedure: Early cranioplasty

  • Active comparator
    Standard-of-care cranioplasty

    Cranioplasty procedure performed after 3 months following the initial decompressive hemicraniectomy.

    Procedure: Standard-of-care cranioplasty

Interventions

  • ProcedureEarly cranioplasty

    Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Early cranioplasty is defined as being performed within 8 weeks following the decompressive hemicraniectomy.

  • ProcedureStandard-of-care cranioplasty

    Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Standard-of-care cranioplasty is defined as being performed after 3 months following the decompressive hemicraniectomy.

06

What researchers measure

Primary outcomes

  1. Functional outcome at 6 months post-decompressive hemicraniectomy

    modified Rankin scale outcome at 6 months post-decompressive hemicraniectomy

    Time frame: 6 months post-decompressive hemicraniectomy

  2. Functional outcome at 12 months post-decompressive hemicraniectomy

    modified Rankin scale outcome at 12 months post-decompressive hemicraniectomy

    Time frame: 12 months post-decompressive hemicraniectomy

Secondary outcomes

  1. Post-cranioplasty seizure

    Post-cranioplasty seizure occurrence, diagnosed clinically or on EEG

    Time frame: 1 month post-cranioplasty

  2. Post-cranioplasty hydrocephalus

    Post-cranioplasty hydrocephalus or need for cerebrospinal fluid diversion

    Time frame: 1 month post-cranioplasty

  3. Post-cranioplasty return to operating room

    All-cause return to operating room after cranioplasty

    Time frame: 1 month post-cranioplasty

  4. Post-cranioplasty infection

    Surgical site or intracranial infection after cranioplasty

    Time frame: 12 months post-cranioplasty

  5. Post-cranioplasty disposition

    Post-cranioplasty disposition (home, acute rehab, subacute rehab, death)

    Time frame: 12 months post-cranioplasty

  6. Post-cranioplasty length of hospital stay

    Post-cranioplasty length of hospital stay

    Time frame: 12 months post-cranioplasty

  7. Readmission within 30 days post-cranioplasty

    Readmission within 30 days post-cranioplasty

    Time frame: 30 days post-cranioplasty

07

Study locations

1 site
  • Thomas Jefferson University Hospitals
    Philadelphia, Pennsylvania 19107, United States
08

References and documents

Publications

  • Patel PD, Khanna O, Gooch MR, Glener SR, Mouchtouris N, Momin AA, Sioutas G, Amllay A, Barsouk A, El Naamani K, Yudkoff C, Wyler DA, Jallo JI, Tjoumakaris S, Jabbour PM, Harrop JS. Clinical Outcomes After Ultra-Early Cranioplasty Using Craniectomy Contour Classification as a Patient Selection Criterion. Oper Neurosurg. 2023 Jul 1;25(1):72-80. doi: 10.1227/ons.0000000000000689. Epub 2023 May 5. PubMed 37166197 ↗
  • Malcolm JG, Rindler RS, Chu JK, Chokshi F, Grossberg JA, Pradilla G, Ahmad FU. Early Cranioplasty is Associated with Greater Neurological Improvement: A Systematic Review and Meta-Analysis. Neurosurgery. 2018 Mar 1;82(3):278-288. doi: 10.1093/neuros/nyx182. PubMed 28419358 ↗
  • Eaton JC, Greil ME, Nistal D, Caldwell DJ, Robinson E, Aljuboori Z, Temkin N, Bonow RH, Chesnut RM. Complications associated with early cranioplasty for patients with traumatic brain injury: a 25-year single-center analysis. J Neurosurg. 2022 Jan 21;137(3):776-781. doi: 10.3171/2021.11.JNS211557. Print 2022 Sep 1. PubMed 35061995 ↗
  • Sethi A, Chee K, Kaakani A, Beauchamp K, Kang J. Ultra-Early Cranioplasty versus Conventional Cranioplasty: A Retrospective Cohort Study at an Academic Level 1 Trauma Center. Neurotrauma Rep. 2022 Aug 1;3(1):286-291. doi: 10.1089/neur.2022.0026. eCollection 2022. PubMed 36060455 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 26 months after the start.

Of 50 non-industry interventional studies with no phase under Craniocerebral Trauma, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 61. This study's planned 26 months is close to that.

Counting every sponsor, half of 51 studies reached it within 26 months; a quarter within 11 and three quarters within 61.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Sep 2027 → Dec 2026 and completion Sep 2027 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2024
First posted
Oct 9, 2024
StartActual
Sep 18, 2024
Primary completionEst.
Dec 1, 2026was Sep 2027
CompletionEst.
Dec 1, 2026was Sep 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 9, 2026
Start date
Sep 1, 2024→Sep 18, 2024
Nov 9, 2026
Primary completion
Sep 1, 2027→Dec 1, 2026
Nov 9, 2026
Study completion
Sep 1, 2027→Dec 1, 2026
Nov 9, 2026
Eligibility
Revised
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Recruiting→Active, not recruiting
    Start date Sep 1, 2024→Sep 18, 2024
    Primary completion Sep 1, 2027→Dec 1, 2026
    Study completion Sep 1, 2027→Dec 1, 2026
    Eligibility Revised
    + 5 other changes: verification date, oversight details, arm descriptions, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06632587
Responsible party
Pious Patel (Resident, Thomas Jefferson University) — Principal investigator
First posted
Oct 9, 2024
Start date
Sep 18, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Nov 9, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion